Exact Mass: 494.4003

Exact Mass Matches: 494.4003

Found 281 metabolites which its exact mass value is equals to given mass value 494.4003, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Sporulenol

Sporulenol; (1R,2R,4aS,4bR,6aS,10aS,10bR,12aS)-2,4b,7,7,10a,12a-Hexamethyl-1-[(3R)-3-(4-methylcyclohexa-1,4-dien-1-yl)butyl]octadecahydrochrysen-2-ol

C35H58O (494.4487)


   

28-Homobrassinolide

15-(5-ethyl-3,4-dihydroxy-6-methylheptan-2-yl)-4,5-dihydroxy-2,16-dimethyl-9-oxatetracyclo[9.7.0.0²,⁷.0¹²,¹⁶]octadecan-8-one

C29H50O6 (494.3607)


28-Homobrassinolide is found in brassicas. 28-Homobrassinolide is a constituent of chinese cabbage (Brassica rapa ssp. pekinensis) Constituent of chinese cabbage (Brassica rapa sspecies pekinensis). 28-Homobrassinolide is found in brassicas.

   

N-Nervonoyl Glutamine

4-carbamoyl-2-(tetracos-15-enamido)butanoic acid

C29H54N2O4 (494.4083)


N-nervonoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Nervonic acid amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Nervonoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Nervonoyl Glutamine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Nervonoyl Lysine

6-amino-2-(tetracos-15-enamido)hexanoic acid

C30H58N2O3 (494.4447)


N-nervonoyl lysine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Nervonic acid amide of Lysine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Nervonoyl Lysine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Nervonoyl Lysine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Heptaethylene glycol monododecyl ether

alpha-Dodecyl-omega-hydroxypoly(oxy-1,2Ethanediyl)

C26H54O8 (494.3818)


   

DG(8:0/18:2(10E,12Z)+=O(9)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C29H50O6 (494.3607)


DG(8:0/18:2(10E,12Z)+=O(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/18:2(10E,12Z)+=O(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:2(10E,12Z)+=O(9)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C29H50O6 (494.3607)


DG(18:2(10E,12Z)+=O(9)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(10E,12Z)+=O(9)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/18:2(10E,12Z)+=O(9))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C29H50O6 (494.3607)


DG(8:0/0:0/18:2(10E,12Z)+=O(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:2(10E,12Z)+=O(9)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C29H50O6 (494.3607)


DG(18:2(10E,12Z)+=O(9)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/18:2(9Z,11E)+=O(13)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C29H50O6 (494.3607)


DG(8:0/18:2(9Z,11E)+=O(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/18:2(9Z,11E)+=O(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:2(9Z,11E)+=O(13)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C29H50O6 (494.3607)


DG(18:2(9Z,11E)+=O(13)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(9Z,11E)+=O(13)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/18:2(9Z,11E)+=O(13))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C29H50O6 (494.3607)


DG(8:0/0:0/18:2(9Z,11E)+=O(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:2(9Z,11E)+=O(13)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C29H50O6 (494.3607)


DG(18:2(9Z,11E)+=O(13)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/18:3(10,12,15)-OH(9)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C29H50O6 (494.3607)


DG(8:0/18:3(10,12,15)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/18:3(10,12,15)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:3(10,12,15)-OH(9)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C29H50O6 (494.3607)


DG(18:3(10,12,15)-OH(9)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(10,12,15)-OH(9)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/18:3(10,12,15)-OH(9))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C29H50O6 (494.3607)


DG(8:0/0:0/18:3(10,12,15)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:3(10,12,15)-OH(9)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C29H50O6 (494.3607)


DG(18:3(10,12,15)-OH(9)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/18:3(9,11,15)-OH(13)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C29H50O6 (494.3607)


DG(8:0/18:3(9,11,15)-OH(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/18:3(9,11,15)-OH(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:3(9,11,15)-OH(13)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C29H50O6 (494.3607)


DG(18:3(9,11,15)-OH(13)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(9,11,15)-OH(13)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/18:3(9,11,15)-OH(13))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C29H50O6 (494.3607)


DG(8:0/0:0/18:3(9,11,15)-OH(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:3(9,11,15)-OH(13)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C29H50O6 (494.3607)


DG(18:3(9,11,15)-OH(13)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Calcium myristate

calcium ditetradecanoate

C28H54CaO4 (494.3648)


It is used as a food additive .

   

Dendronesterol B

Dendronesterol B

C29H50O6 (494.3607)


   

Ekeberin D3

Ekeberin D3

C30H54O5 (494.3971)


   

Secotenuifolide A

Secotenuifolide A

C31H58O4 (494.4335)


   

(E)-1-acetoxy-1,4-dihydro-2-methyl-4-oxo-3-phytylnaphthalene

(E)-1-acetoxy-1,4-dihydro-2-methyl-4-oxo-3-phytylnaphthalene

C33H50O3 (494.376)


   

2-hydroxymethyl-2,3,22,23-tetrahydroxy-6,10,15,19,23-pentamethyl-6,10,14,18-tetracosatetraene

2-hydroxymethyl-2,3,22,23-tetrahydroxy-6,10,15,19,23-pentamethyl-6,10,14,18-tetracosatetraene

C30H54O5 (494.3971)


   
   

Schkuhrianol

Schkuhrianol

C29H50O6 (494.3607)


   

1-O-Dodecanoyl-Tetrahydro-2-(1-hydroxy-9-nonenyl)-5-pentyl-3-furanol

1-O-Dodecanoyl-Tetrahydro-2-(1-hydroxy-9-nonenyl)-5-pentyl-3-furanol

C31H58O4 (494.4335)


   

Quassiol|quassiol A

Quassiol|quassiol A

C30H54O5 (494.3971)


   

ACMC-20ll4u

ACMC-20ll4u

C31H58O4 (494.4335)


   

DTXSID70702160

DTXSID70702160

C35H58O (494.4487)


   

pellynol F

pellynol F

C33H50O3 (494.376)


   

(?)-petrosynoic acid B

(?)-petrosynoic acid B

C33H50O3 (494.376)


   

2,3,5,22,23-pentahydroxy-2,6,10,15,19,23-hexamethyl-6,10,14,18-tetracosatetraene

2,3,5,22,23-pentahydroxy-2,6,10,15,19,23-hexamethyl-6,10,14,18-tetracosatetraene

C30H54O5 (494.3971)


   

(?)-pellynols F

(?)-pellynols F

C33H50O3 (494.376)


   

(1S, 8E,12E)-1-((2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-4,9,13,17-tetramethyl octadeca-8,12,16-triene-1,4,5-triol|sapelenin I

(1S, 8E,12E)-1-((2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-4,9,13,17-tetramethyl octadeca-8,12,16-triene-1,4,5-triol|sapelenin I

C30H54O5 (494.3971)


   

20(R)-25-methoxyl-dammarane-3beta,6alpha,12beta,20-tetrol

20(R)-25-methoxyl-dammarane-3beta,6alpha,12beta,20-tetrol

C30H54O5 (494.3971)


   

3-O-Dodecanoyl-Tetrahydro-2-(1-hydroxy-9-nonenyl)-5-pentyl-3-furanol

3-O-Dodecanoyl-Tetrahydro-2-(1-hydroxy-9-nonenyl)-5-pentyl-3-furanol

C31H58O4 (494.4335)


   

ethyl (22S,25R)-3alpha,12alpha,15alpha,22-tetrahydroxy-5beta-cholestan-26-oate

ethyl (22S,25R)-3alpha,12alpha,15alpha,22-tetrahydroxy-5beta-cholestan-26-oate

C29H50O6 (494.3607)


   

(5Z,7E)-(1S,3R)-24,24-difluoro-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol

24,24-difluoro-1α,25-dihydroxy-26,27-dimethyl-24a-homovitamin D3 / 24,24-difluoro-1α,25-dihydroxy-26,27-dimethyl-24a-homocholecalciferol

C30H48F2O3 (494.3571)


   

Isohomobrassinolide

15-(5-ethyl-3,4-dihydroxy-6-methylheptan-2-yl)-4,5-dihydroxy-2,16-dimethyl-9-oxatetracyclo[9.7.0.0^{2,7}.0^{12,16}]octadecan-8-one

C29H50O6 (494.3607)


   

FA 33:8;O

31R-hydroxytritriaconta-4Z,29E-dien-2,18,32-triynoic acid

C33H50O3 (494.376)


   

Heptaethylene glycol monododecyl ether

3,6,9,12,15,18,21-Heptaoxatritriacontan-1-ol

C26H54O8 (494.3818)


D019999 - Pharmaceutical Solutions > D012597 - Sclerosing Solutions D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D013501 - Surface-Active Agents > D003902 - Detergents D001697 - Biomedical and Dental Materials D002317 - Cardiovascular Agents

   

22(s),23(s)-homobrassinolide

22(s),23(s)-homobrassinolide

C29H50O6 (494.3607)


   

benzyldimethyl[3-[(1-oxoisooctadecyl)amino]propyl]ammonium chloride

benzyldimethyl[3-[(1-oxoisooctadecyl)amino]propyl]ammonium chloride

C30H55ClN2O (494.4003)


   

tris(2-(2-Butoxyethoxy)ethyl)orthoborate

tris(2-(2-Butoxyethoxy)ethyl)orthoborate

C24H51BO9 (494.3626)


   

benzyldimethyl[3-[(1-oxooctadecyl)amino]propyl]ammonium chloride

benzyldimethyl[3-[(1-oxooctadecyl)amino]propyl]ammonium chloride

C30H55ClN2O (494.4003)


   

DILAURYL PHENYL PHOSPHITE

DILAURYL PHENYL PHOSPHITE

C30H55O3P (494.3889)


   

Homobrassinolide

22S,23S-Homobrassinolide

C29H50O6 (494.3607)


28-Homobrassinolide is a phytosteroid. 28-Homobrassinolide can be used for the research of cholesterol and glucose homeostasis[1].

   

trimethyl-3-[(1-oxooctadecyl)amino]propylammonium methyl sulphate

trimethyl-3-[(1-oxooctadecyl)amino]propylammonium methyl sulphate

C25H54N2O5S (494.3753)


   

(2Z,6Z,10Z,14Z,18E,22E)-3,7,11,15,19,23,27-Heptamethyloctacosa-2,6,10,14,18,22,26-heptaene-1-ol

(2Z,6Z,10Z,14Z,18E,22E)-3,7,11,15,19,23,27-Heptamethyloctacosa-2,6,10,14,18,22,26-heptaene-1-ol

C35H58O (494.4487)


   

(2R,4aS,4bR,6aS,10aS,10bR,12aS)-2,4b,7,7,10a,12a-hexamethyl-1-[(3R)-3-(4-methylcyclohexa-1,4-dien-1-yl)butyl]-3,4,4a,5,6,6a,8,9,10,10b,11,12-dodecahydro-1H-chrysen-2-ol

(2R,4aS,4bR,6aS,10aS,10bR,12aS)-2,4b,7,7,10a,12a-hexamethyl-1-[(3R)-3-(4-methylcyclohexa-1,4-dien-1-yl)butyl]-3,4,4a,5,6,6a,8,9,10,10b,11,12-dodecahydro-1H-chrysen-2-ol

C35H58O (494.4487)


   

N-Nervonoyl Lysine

N-Nervonoyl Lysine

C30H58N2O3 (494.4447)


   

N-Nervonoyl Glutamine

N-Nervonoyl Glutamine

C29H54N2O4 (494.4083)


   

DG(8:0/18:2(10E,12Z)+=O(9)/0:0)

DG(8:0/18:2(10E,12Z)+=O(9)/0:0)

C29H50O6 (494.3607)


   

DG(18:2(10E,12Z)+=O(9)/8:0/0:0)

DG(18:2(10E,12Z)+=O(9)/8:0/0:0)

C29H50O6 (494.3607)


   

DG(8:0/0:0/18:2(10E,12Z)+=O(9))

DG(8:0/0:0/18:2(10E,12Z)+=O(9))

C29H50O6 (494.3607)


   

DG(18:2(10E,12Z)+=O(9)/0:0/8:0)

DG(18:2(10E,12Z)+=O(9)/0:0/8:0)

C29H50O6 (494.3607)


   

DG(8:0/18:2(9Z,11E)+=O(13)/0:0)

DG(8:0/18:2(9Z,11E)+=O(13)/0:0)

C29H50O6 (494.3607)


   

DG(18:2(9Z,11E)+=O(13)/8:0/0:0)

DG(18:2(9Z,11E)+=O(13)/8:0/0:0)

C29H50O6 (494.3607)


   

DG(8:0/0:0/18:2(9Z,11E)+=O(13))

DG(8:0/0:0/18:2(9Z,11E)+=O(13))

C29H50O6 (494.3607)


   

DG(18:2(9Z,11E)+=O(13)/0:0/8:0)

DG(18:2(9Z,11E)+=O(13)/0:0/8:0)

C29H50O6 (494.3607)


   

[(2S)-1-hydroxy-3-octanoyloxypropan-2-yl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

[(2S)-1-hydroxy-3-octanoyloxypropan-2-yl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C29H50O6 (494.3607)


   

[(2S)-3-hydroxy-2-octanoyloxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

[(2S)-3-hydroxy-2-octanoyloxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C29H50O6 (494.3607)


   

[(2R)-2-hydroxy-3-octanoyloxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

[(2R)-2-hydroxy-3-octanoyloxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C29H50O6 (494.3607)


   

[(2S)-2-hydroxy-3-octanoyloxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

[(2S)-2-hydroxy-3-octanoyloxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C29H50O6 (494.3607)


   

[(2S)-1-hydroxy-3-octanoyloxypropan-2-yl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

[(2S)-1-hydroxy-3-octanoyloxypropan-2-yl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C29H50O6 (494.3607)


   

[(2S)-3-hydroxy-2-octanoyloxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

[(2S)-3-hydroxy-2-octanoyloxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C29H50O6 (494.3607)


   

[(2R)-2-hydroxy-3-octanoyloxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

[(2R)-2-hydroxy-3-octanoyloxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C29H50O6 (494.3607)


   

[(2S)-2-hydroxy-3-octanoyloxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

[(2S)-2-hydroxy-3-octanoyloxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C29H50O6 (494.3607)


   

[3-Carboxy-2-[13-(3,4-dimethyl-5-propylfuran-2-yl)tridecanoyloxy]propyl]-trimethylazanium

[3-Carboxy-2-[13-(3,4-dimethyl-5-propylfuran-2-yl)tridecanoyloxy]propyl]-trimethylazanium

C29H52NO5+ (494.3845)


   

[3-Carboxy-2-[11-(3,4-dimethyl-5-pentylfuran-2-yl)undecanoyloxy]propyl]-trimethylazanium

[3-Carboxy-2-[11-(3,4-dimethyl-5-pentylfuran-2-yl)undecanoyloxy]propyl]-trimethylazanium

C29H52NO5+ (494.3845)


   

(-)-Duryne D

(-)-Duryne D

C34H54O2 (494.4124)


An enyne that is (4E,13Z,19Z,30E)-tetratriaconta-4,13,19,30-tetraene-1,33-diyne substituted by hydroxy groups at positions 3 and 32 (the 3R,32R-stereoisomer). It has been isolated from the marine sponge Petrosia.

   

2-[[(2R)-3-[(Z)-heptadec-1-enoxy]-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-3-[(Z)-heptadec-1-enoxy]-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C25H53NO6P+ (494.361)


   

[1-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] butanoate

[1-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] butanoate

C31H58O4 (494.4335)


   

[1-[(11Z,14Z)-henicosa-11,14-dienoxy]-3-hydroxypropan-2-yl] heptanoate

[1-[(11Z,14Z)-henicosa-11,14-dienoxy]-3-hydroxypropan-2-yl] heptanoate

C31H58O4 (494.4335)


   

[1-[(13Z,16Z)-docosa-13,16-dienoxy]-3-hydroxypropan-2-yl] hexanoate

[1-[(13Z,16Z)-docosa-13,16-dienoxy]-3-hydroxypropan-2-yl] hexanoate

C31H58O4 (494.4335)


   

(1-hydroxy-3-octoxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

(1-hydroxy-3-octoxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

C31H58O4 (494.4335)


   

[1-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] nonanoate

[1-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] nonanoate

C31H58O4 (494.4335)


   

[1-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] octanoate

[1-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] octanoate

C31H58O4 (494.4335)


   

[1-[(15Z,18Z)-hexacosa-15,18-dienoxy]-3-hydroxypropan-2-yl] acetate

[1-[(15Z,18Z)-hexacosa-15,18-dienoxy]-3-hydroxypropan-2-yl] acetate

C31H58O4 (494.4335)


   

(1-hydroxy-3-nonoxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

(1-hydroxy-3-nonoxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

C31H58O4 (494.4335)


   

[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] undecanoate

[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] undecanoate

C31H58O4 (494.4335)


   

(1-dodecoxy-3-hydroxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

(1-dodecoxy-3-hydroxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

C31H58O4 (494.4335)


   

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-tetradec-9-enoate

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-tetradec-9-enoate

C31H58O4 (494.4335)


   

[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] dodecanoate

[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] dodecanoate

C31H58O4 (494.4335)


   

[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] decanoate

[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] decanoate

C31H58O4 (494.4335)


   

(1-decoxy-3-hydroxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

(1-decoxy-3-hydroxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

C31H58O4 (494.4335)


   

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

C31H58O4 (494.4335)


   

(1-hydroxy-3-undecoxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

(1-hydroxy-3-undecoxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

C31H58O4 (494.4335)


   

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-tridec-9-enoate

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-tridec-9-enoate

C31H58O4 (494.4335)


   
   
   

[3-carboxy-2-[(14E,16E)-tricosa-14,16-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(14E,16E)-tricosa-14,16-dienoyl]oxypropyl]-trimethylazanium

C30H56NO4+ (494.4209)


   

[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (Z)-tetradec-9-enoate

[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (Z)-tetradec-9-enoate

C34H54O2 (494.4124)


   

Fahfa 9:0/22:1

Fahfa 9:0/22:1

C31H58O4 (494.4335)


   

Fahfa 24:1/7:0

Fahfa 24:1/7:0

C31H58O4 (494.4335)


   

Fahfa 7:0/24:1

Fahfa 7:0/24:1

C31H58O4 (494.4335)


   

Fahfa 22:1/9:0

Fahfa 22:1/9:0

C31H58O4 (494.4335)


   

Fahfa 26:1/5:0

Fahfa 26:1/5:0

C31H58O4 (494.4335)


   

Fahfa 5:0/26:1

Fahfa 5:0/26:1

C31H58O4 (494.4335)


   

Fahfa 15:0/16:1

Fahfa 15:0/16:1

C31H58O4 (494.4335)


   

Fahfa 19:1/12:0

Fahfa 19:1/12:0

C31H58O4 (494.4335)


   

Fahfa 11:0/20:1

Fahfa 11:0/20:1

C31H58O4 (494.4335)


   

Fahfa 21:1/10:0

Fahfa 21:1/10:0

C31H58O4 (494.4335)


   

Fahfa 12:0/19:1

Fahfa 12:0/19:1

C31H58O4 (494.4335)


   

Fahfa 17:0/14:1

Fahfa 17:0/14:1

C31H58O4 (494.4335)


   

Fahfa 18:1/13:0

Fahfa 18:1/13:0

C31H58O4 (494.4335)


   

Fahfa 20:1/11:0

Fahfa 20:1/11:0

C31H58O4 (494.4335)


   

Fahfa 18:0/13:1

Fahfa 18:0/13:1

C31H58O4 (494.4335)


   

Fahfa 13:1/18:0

Fahfa 13:1/18:0

C31H58O4 (494.4335)


   

Fahfa 14:0/17:1

Fahfa 14:0/17:1

C31H58O4 (494.4335)


   

Fahfa 13:0/18:1

Fahfa 13:0/18:1

C31H58O4 (494.4335)


   

Fahfa 17:1/14:0

Fahfa 17:1/14:0

C31H58O4 (494.4335)


   

Fahfa 16:0/15:1

Fahfa 16:0/15:1

C31H58O4 (494.4335)


   

Fahfa 10:0/21:1

Fahfa 10:0/21:1

C31H58O4 (494.4335)


   

Fahfa 15:1/16:0

Fahfa 15:1/16:0

C31H58O4 (494.4335)


   

(13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-13,16,19,22,25,28,31-heptaenoic acid

(13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-13,16,19,22,25,28,31-heptaenoic acid

C34H54O2 (494.4124)


   

(1-hydroxy-3-octanoyloxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

(1-hydroxy-3-octanoyloxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

C30H54O5 (494.3971)


   

(1-hydroxy-3-nonanoyloxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

(1-hydroxy-3-nonanoyloxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

C30H54O5 (494.3971)


   

(1-hydroxy-3-undecanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

(1-hydroxy-3-undecanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

C30H54O5 (494.3971)


   

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-tetradec-9-enoate

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-tetradec-9-enoate

C30H54O5 (494.3971)


   

(1-decanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

(1-decanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

C30H54O5 (494.3971)


   

(1-heptanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

(1-heptanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

C30H54O5 (494.3971)


   

(1-hydroxy-3-propanoyloxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate

(1-hydroxy-3-propanoyloxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate

C30H54O5 (494.3971)


   

(1-hexanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate

(1-hexanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate

C30H54O5 (494.3971)


   

(1-hydroxy-3-pentanoyloxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate

(1-hydroxy-3-pentanoyloxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate

C30H54O5 (494.3971)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(3-hydroxy-2-undecanoyloxypropyl) (4E,7E)-hexadeca-4,7-dienoate

(3-hydroxy-2-undecanoyloxypropyl) (4E,7E)-hexadeca-4,7-dienoate

C30H54O5 (494.3971)


   

[(2S)-1-decanoyloxy-3-hydroxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate

[(2S)-1-decanoyloxy-3-hydroxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate

C30H54O5 (494.3971)


   

[(2S)-2-decanoyloxy-3-hydroxypropyl] (9E,12E)-heptadeca-9,12-dienoate

[(2S)-2-decanoyloxy-3-hydroxypropyl] (9E,12E)-heptadeca-9,12-dienoate

C30H54O5 (494.3971)


   

2-[[3-[(Z)-heptadec-9-enoxy]-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(Z)-heptadec-9-enoxy]-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C25H53NO6P+ (494.361)


   

TG(26:2)

TG(6:0_6:0_14:2)

C29H50O6 (494.3607)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

DG(27:2)

DG(17:0_10:2)

C30H54O5 (494.3971)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Tetratriacontaheptaenoic acid

Tetratriacontaheptaenoic acid

C34H54O2 (494.4124)


   

NA-Trp 20:2(11Z,14Z)

NA-Trp 20:2(11Z,14Z)

C31H46N2O3 (494.3508)


   
   

FAHFA 10:0/O-21:1

FAHFA 10:0/O-21:1

C31H58O4 (494.4335)


   

FAHFA 10:1/O-21:0

FAHFA 10:1/O-21:0

C31H58O4 (494.4335)


   

FAHFA 11:0/O-20:1

FAHFA 11:0/O-20:1

C31H58O4 (494.4335)


   

FAHFA 11:1/O-20:0

FAHFA 11:1/O-20:0

C31H58O4 (494.4335)


   

FAHFA 12:0/O-19:1

FAHFA 12:0/O-19:1

C31H58O4 (494.4335)


   

FAHFA 12:1/O-19:0

FAHFA 12:1/O-19:0

C31H58O4 (494.4335)


   

FAHFA 13:0/O-18:1

FAHFA 13:0/O-18:1

C31H58O4 (494.4335)


   

FAHFA 13:1(12E)/12O-18:0

FAHFA 13:1(12E)/12O-18:0

C31H58O4 (494.4335)


   

FAHFA 13:1/O-18:0

FAHFA 13:1/O-18:0

C31H58O4 (494.4335)


   

FAHFA 14:0/O-17:1

FAHFA 14:0/O-17:1

C31H58O4 (494.4335)


   

FAHFA 14:1/O-17:0

FAHFA 14:1/O-17:0

C31H58O4 (494.4335)


   

FAHFA 15:0/O-16:1

FAHFA 15:0/O-16:1

C31H58O4 (494.4335)


   

FAHFA 15:1(9Z)/3O-16:0

FAHFA 15:1(9Z)/3O-16:0

C31H58O4 (494.4335)


   

FAHFA 15:1/O-16:0

FAHFA 15:1/O-16:0

C31H58O4 (494.4335)


   

FAHFA 16:0/O-15:1

FAHFA 16:0/O-15:1

C31H58O4 (494.4335)


   

FAHFA 16:1(9Z)/15O-15:0

FAHFA 16:1(9Z)/15O-15:0

C31H58O4 (494.4335)


   

FAHFA 16:1/O-15:0

FAHFA 16:1/O-15:0

C31H58O4 (494.4335)


   

FAHFA 17:0/O-14:1

FAHFA 17:0/O-14:1

C31H58O4 (494.4335)


   

FAHFA 17:1(9Z)/2O-14:0

FAHFA 17:1(9Z)/2O-14:0

C31H58O4 (494.4335)


   

FAHFA 17:1/O-14:0

FAHFA 17:1/O-14:0

C31H58O4 (494.4335)


   

FAHFA 18:0/O-13:1

FAHFA 18:0/O-13:1

C31H58O4 (494.4335)


   

FAHFA 18:1(9Z)/3O-13:0

FAHFA 18:1(9Z)/3O-13:0

C31H58O4 (494.4335)


   

FAHFA 18:1/O-13:0

FAHFA 18:1/O-13:0

C31H58O4 (494.4335)


   

FAHFA 19:0/O-12:1

FAHFA 19:0/O-12:1

C31H58O4 (494.4335)


   

FAHFA 19:1(10Z)/3O-12:0

FAHFA 19:1(10Z)/3O-12:0

C31H58O4 (494.4335)


   

FAHFA 19:1/O-12:0

FAHFA 19:1/O-12:0

C31H58O4 (494.4335)


   

FAHFA 20:0/O-11:1

FAHFA 20:0/O-11:1

C31H58O4 (494.4335)


   

FAHFA 20:1(11Z)/3O-11:0

FAHFA 20:1(11Z)/3O-11:0

C31H58O4 (494.4335)


   

FAHFA 20:1/O-11:0

FAHFA 20:1/O-11:0

C31H58O4 (494.4335)


   

FAHFA 21:0/O-10:1

FAHFA 21:0/O-10:1

C31H58O4 (494.4335)


   

FAHFA 21:1/O-10:0

FAHFA 21:1/O-10:0

C31H58O4 (494.4335)


   

FAHFA 22:0/O-9:1

FAHFA 22:0/O-9:1

C31H58O4 (494.4335)


   

FAHFA 22:1(13Z)/3O-9:0

FAHFA 22:1(13Z)/3O-9:0

C31H58O4 (494.4335)


   

FAHFA 22:1/O-9:0

FAHFA 22:1/O-9:0

C31H58O4 (494.4335)


   

FAHFA 23:0/O-8:1

FAHFA 23:0/O-8:1

C31H58O4 (494.4335)


   

FAHFA 23:1(14Z)/3O-8:0

FAHFA 23:1(14Z)/3O-8:0

C31H58O4 (494.4335)


   

FAHFA 23:1/O-8:0

FAHFA 23:1/O-8:0

C31H58O4 (494.4335)


   

FAHFA 31:1;O

FAHFA 31:1;O

C31H58O4 (494.4335)


   

FAHFA 8:0/O-23:1

FAHFA 8:0/O-23:1

C31H58O4 (494.4335)


   

FAHFA 8:1/O-23:0

FAHFA 8:1/O-23:0

C31H58O4 (494.4335)


   

FAHFA 9:0/O-22:1

FAHFA 9:0/O-22:1

C31H58O4 (494.4335)


   

FAHFA 9:1/O-22:0

FAHFA 9:1/O-22:0

C31H58O4 (494.4335)


   

DG 10:0_17:2

DG 10:0_17:2

C30H54O5 (494.3971)


   
   
   

DG P-14:0_14:1

DG P-14:0_14:1

C31H58O4 (494.4335)


   

DG P-16:1_12:0

DG P-16:1_12:0

C31H58O4 (494.4335)


   

DG P-18:1_10:0

DG P-18:1_10:0

C31H58O4 (494.4335)


   
   

ST 23:0;O;Hex

ST 23:0;O;Hex

C29H50O6 (494.3607)


   
   

methyl 2-(1-hydroxy-2-oxopropyl)heptacos-2-enoate

methyl 2-(1-hydroxy-2-oxopropyl)heptacos-2-enoate

C31H58O4 (494.4335)


   

(3r,4e,30e,32r)-tetratriaconta-4,13,19,30-tetraen-1,33-diyne-3,32-diol

(3r,4e,30e,32r)-tetratriaconta-4,13,19,30-tetraen-1,33-diyne-3,32-diol

C34H54O2 (494.4124)


   

(1r,4e,8e,12r,13r)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9,13,17-tetramethyloctadeca-4,8,16-triene-1,12,13-triol

(1r,4e,8e,12r,13r)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9,13,17-tetramethyloctadeca-4,8,16-triene-1,12,13-triol

C30H54O5 (494.3971)


   

6-{3,5,5a,7-tetrahydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl}-3-isopropylheptanoic acid

6-{3,5,5a,7-tetrahydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl}-3-isopropylheptanoic acid

C29H50O6 (494.3607)


   

3-(3,4-dihydroxy-5-methoxyphenyl)propyl 3-hydroxy-11-methyloctadecanoate

3-(3,4-dihydroxy-5-methoxyphenyl)propyl 3-hydroxy-11-methyloctadecanoate

C29H50O6 (494.3607)


   

(1r,4e,8e,12e,16r)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9,13,17-tetramethyloctadeca-4,8,12-triene-1,16,17-triol

(1r,4e,8e,12e,16r)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9,13,17-tetramethyloctadeca-4,8,12-triene-1,16,17-triol

C30H54O5 (494.3971)


   

(2s,3s,6e,10e,14e,18e,22s)-2,6,10,15,19,23-hexamethyltetracosa-6,10,14,18-tetraene-1,2,3,22,23-pentol

(2s,3s,6e,10e,14e,18e,22s)-2,6,10,15,19,23-hexamethyltetracosa-6,10,14,18-tetraene-1,2,3,22,23-pentol

C30H54O5 (494.3971)


   

(28s)-28-hydroxyhentriacontane-7,16,18-trione

(28s)-28-hydroxyhentriacontane-7,16,18-trione

C31H58O4 (494.4335)


   

1-(1-hydroxy-5-methoxy-5-methylhexyl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthrene-5,7,11-triol

1-(1-hydroxy-5-methoxy-5-methylhexyl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthrene-5,7,11-triol

C30H54O5 (494.3971)


   

(1r,4e,8e,12e,16r)-1-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9,13,17-tetramethyloctadeca-4,8,12-triene-1,16,17-triol

(1r,4e,8e,12e,16r)-1-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9,13,17-tetramethyloctadeca-4,8,12-triene-1,16,17-triol

C30H54O5 (494.3971)


   

(2e,4z,6r,15r,16s)-15-(c-hydroxycarbonimidoyloxy)-n-[(2s)-1-hydroxypropan-2-yl]-2,6,16-trimethyldocosa-2,4-dienimidic acid

(2e,4z,6r,15r,16s)-15-(c-hydroxycarbonimidoyloxy)-n-[(2s)-1-hydroxypropan-2-yl]-2,6,16-trimethyldocosa-2,4-dienimidic acid

C29H54N2O4 (494.4083)


   

[(1r,3r,3as,3br,5r,5ar,7s,9ar,9bs,11as)-3,5,5a,7-tetrahydroxy-9a-methyl-1-[(2r)-6-methylheptan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-11a-yl]methyl acetate

[(1r,3r,3as,3br,5r,5ar,7s,9ar,9bs,11as)-3,5,5a,7-tetrahydroxy-9a-methyl-1-[(2r)-6-methylheptan-2-yl]-tetradecahydrocyclopenta[a]phenanthren-11a-yl]methyl acetate

C29H50O6 (494.3607)


   

15-(c-hydroxycarbonimidoyloxy)-n-(1-hydroxypropan-2-yl)-2,6,16-trimethyldocosa-2,4-dienimidic acid

15-(c-hydroxycarbonimidoyloxy)-n-(1-hydroxypropan-2-yl)-2,6,16-trimethyldocosa-2,4-dienimidic acid

C29H54N2O4 (494.4083)


   

1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9,13,17-tetramethyloctadeca-4,8,12-triene-1,16,17-triol

1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9,13,17-tetramethyloctadeca-4,8,12-triene-1,16,17-triol

C30H54O5 (494.3971)


   

3-(3,4-dihydroxy-5-methoxyphenyl)propyl (3s,11s)-3-hydroxy-11-methyloctadecanoate

3-(3,4-dihydroxy-5-methoxyphenyl)propyl (3s,11s)-3-hydroxy-11-methyloctadecanoate

C29H50O6 (494.3607)


   

(29e)-tritriacont-29-en-2,4,17,32-tetrayne-1,6,31-triol

(29e)-tritriacont-29-en-2,4,17,32-tetrayne-1,6,31-triol

C33H50O3 (494.376)


   

(3r,6r)-6-[(1r,3s,3as,3br,5r,5ar,7s,9ar,9bs,11ar)-3,5,5a,7-tetrahydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]-3-isopropylheptanoic acid

(3r,6r)-6-[(1r,3s,3as,3br,5r,5ar,7s,9ar,9bs,11ar)-3,5,5a,7-tetrahydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]-3-isopropylheptanoic acid

C29H50O6 (494.3607)


   

2,6,10,15,19,23-hexamethyltetracosa-6,10,14,18-tetraene-1,2,3,22,23-pentol

2,6,10,15,19,23-hexamethyltetracosa-6,10,14,18-tetraene-1,2,3,22,23-pentol

C30H54O5 (494.3971)


   

(1r,2r,7r,11r,12s,16s)-15-(5-ethyl-3,4-dihydroxy-6-methylheptan-2-yl)-4,5-dihydroxy-2,16-dimethyl-9-oxatetracyclo[9.7.0.0²,⁷.0¹²,¹⁶]octadecan-8-one

(1r,2r,7r,11r,12s,16s)-15-(5-ethyl-3,4-dihydroxy-6-methylheptan-2-yl)-4,5-dihydroxy-2,16-dimethyl-9-oxatetracyclo[9.7.0.0²,⁷.0¹²,¹⁶]octadecan-8-one

C29H50O6 (494.3607)


   

(1s,4e,8e,12e,16r)-1-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9,13,17-tetramethyloctadeca-4,8,12-triene-1,16,17-triol

(1s,4e,8e,12e,16r)-1-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9,13,17-tetramethyloctadeca-4,8,12-triene-1,16,17-triol

C30H54O5 (494.3971)


   

(1r,4e,8r,9r)-1-[(2s,5r)-5-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-2-methyloxolan-2-yl]-5,9,13-trimethyltetradeca-4,12-diene-1,8,9-triol

(1r,4e,8r,9r)-1-[(2s,5r)-5-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-2-methyloxolan-2-yl]-5,9,13-trimethyltetradeca-4,12-diene-1,8,9-triol

C30H54O5 (494.3971)


   

1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9,13,17-tetramethyloctadeca-4,8,16-triene-1,12,13-triol

1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9,13,17-tetramethyloctadeca-4,8,16-triene-1,12,13-triol

C30H54O5 (494.3971)


   

2-[(3r,3ar,5s,8r,8as)-8-hydroxy-3,8-dimethyl-octahydro-1h-azulen-5-yl]-2-hydroxypropyl hexadecanoate

2-[(3r,3ar,5s,8r,8as)-8-hydroxy-3,8-dimethyl-octahydro-1h-azulen-5-yl]-2-hydroxypropyl hexadecanoate

C31H58O4 (494.4335)


   

1-[5-(2-hydroxy-6-methylhept-5-en-2-yl)-2-methyloxolan-2-yl]-5,9,13-trimethyltetradeca-4,12-diene-1,8,9-triol

1-[5-(2-hydroxy-6-methylhept-5-en-2-yl)-2-methyloxolan-2-yl]-5,9,13-trimethyltetradeca-4,12-diene-1,8,9-triol

C30H54O5 (494.3971)


   

(1r,2s,4as,4bs,6ar,10as,10br,12as)-2,4b,7,7,10a,12a-hexamethyl-1-[(3s)-3-(4-methylcyclohexa-1,4-dien-1-yl)butyl]-dodecahydro-1h-chrysen-2-ol

(1r,2s,4as,4bs,6ar,10as,10br,12as)-2,4b,7,7,10a,12a-hexamethyl-1-[(3s)-3-(4-methylcyclohexa-1,4-dien-1-yl)butyl]-dodecahydro-1h-chrysen-2-ol

C35H58O (494.4487)


   

2-hydroxy-2-(8-hydroxy-3,8-dimethyl-octahydro-1h-azulen-5-yl)propyl hexadecanoate

2-hydroxy-2-(8-hydroxy-3,8-dimethyl-octahydro-1h-azulen-5-yl)propyl hexadecanoate

C31H58O4 (494.4335)


   

methyl (2e)-2-[(1r)-1-hydroxy-2-oxopropyl]heptacos-2-enoate

methyl (2e)-2-[(1r)-1-hydroxy-2-oxopropyl]heptacos-2-enoate

C31H58O4 (494.4335)


   

(1s,3ar,3br,5s,5ar,7s,9ar,9br,11r,11ar)-1-[(1r)-1-hydroxy-5-methoxy-5-methylhexyl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthrene-5,7,11-triol

(1s,3ar,3br,5s,5ar,7s,9ar,9br,11r,11ar)-1-[(1r)-1-hydroxy-5-methoxy-5-methylhexyl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthrene-5,7,11-triol

C30H54O5 (494.3971)


   

methyl (2e)-2-[(1s)-1-hydroxy-2-oxopropyl]heptacos-2-enoate

methyl (2e)-2-[(1s)-1-hydroxy-2-oxopropyl]heptacos-2-enoate

C31H58O4 (494.4335)


   

(4e)-1-[5-(2-hydroxy-6-methylhept-5-en-2-yl)-2,5-dimethyloxolan-2-yl]-5,13-dimethyltetradeca-4,12-diene-1,8,9-triol

(4e)-1-[5-(2-hydroxy-6-methylhept-5-en-2-yl)-2,5-dimethyloxolan-2-yl]-5,13-dimethyltetradeca-4,12-diene-1,8,9-triol

C30H54O5 (494.3971)


   

2-methoxy-6,10,15,19,23-pentamethyltetracosa-6,10,14,18-tetraene-2,3,22,23-tetrol

2-methoxy-6,10,15,19,23-pentamethyltetracosa-6,10,14,18-tetraene-2,3,22,23-tetrol

C30H54O5 (494.3971)


   

3-(3-hydroxy-4,5-dimethoxyphenyl)propyl 3-hydroxy-11-methylheptadecanoate

3-(3-hydroxy-4,5-dimethoxyphenyl)propyl 3-hydroxy-11-methylheptadecanoate

C29H50O6 (494.3607)


   

[3,5,5a,7-tetrahydroxy-9a-methyl-1-(6-methylheptan-2-yl)-tetradecahydrocyclopenta[a]phenanthren-11a-yl]methyl acetate

[3,5,5a,7-tetrahydroxy-9a-methyl-1-(6-methylheptan-2-yl)-tetradecahydrocyclopenta[a]phenanthren-11a-yl]methyl acetate

C29H50O6 (494.3607)


   

28-hydroxyhentriacontane-7,16,18-trione

28-hydroxyhentriacontane-7,16,18-trione

C31H58O4 (494.4335)


   

(2s,3r,6e,10e,14e,18e,22r)-2,6,10,15,19,23-hexamethyltetracosa-6,10,14,18-tetraene-1,2,3,22,23-pentol

(2s,3r,6e,10e,14e,18e,22r)-2,6,10,15,19,23-hexamethyltetracosa-6,10,14,18-tetraene-1,2,3,22,23-pentol

C30H54O5 (494.3971)


   

3-(3-hydroxy-4,5-dimethoxyphenyl)propyl (3s,11s)-3-hydroxy-11-methylheptadecanoate

3-(3-hydroxy-4,5-dimethoxyphenyl)propyl (3s,11s)-3-hydroxy-11-methylheptadecanoate

C29H50O6 (494.3607)


   

(4e,8e)-1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9,13,17-tetramethyloctadeca-4,8,16-triene-1,12,13-triol

(4e,8e)-1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9,13,17-tetramethyloctadeca-4,8,16-triene-1,12,13-triol

C30H54O5 (494.3971)


   

2,4b,7,7,10a,12a-hexamethyl-1-[3-(4-methylcyclohexa-1,4-dien-1-yl)butyl]-dodecahydro-1h-chrysen-2-ol

2,4b,7,7,10a,12a-hexamethyl-1-[3-(4-methylcyclohexa-1,4-dien-1-yl)butyl]-dodecahydro-1h-chrysen-2-ol

C35H58O (494.4487)